Search

everythinglearnresearchcommunity

for

Search:↓

The congress highlighted concerns about the effectiveness of over-the-counter nail treatments, the link between hair loss and daily care products, and the safety of skin treatments during COVID-19.

Growth factors-rich plasma treatments can significantly speed up wound healing and tissue regeneration.

PRP shows promise for short-term hair growth, especially in young men.

Ayurvedic treatments can improve symptoms and quality of life for systemic sclerosis patients.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

A young girl with skin and scalp conditions showed some improvement with treatment.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Neuropathic pruritus is a commonly overlooked and wrongly diagnosed type of chronic itching that is hard to treat.

Proper periodontal treatment with xenograft effectively manages aggressive periodontitis in SLE patients.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Oral tofacitinib successfully treated total body hair loss in one patient.

A man with syphilitic alopecia and neurosyphilis was successfully treated with penicillin, leading to symptom improvement and resolution of hair loss.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Lupus Panniculitis can be an early sign of Systemic Lupus Erythematosus.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

A woman with a rare form of multiple myeloma had a headache and a skull mass, which led to her diagnosis after tests and a biopsy.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Psychosis can be an early sign of neuropsychiatric lupus, treatable with tailored medication.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

COVID-19 can cause skin issues like hives, rashes, and chickenpox-like eruptions, with women aged 31-40 being the most affected.

Health experts should not ignore their own health issues and seeking treatment is important for their well-being and work.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.